Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 February, 2018 22:54 IST
ICRA upgrades credit rating of Dwarikesh Sugar's Rs 5.99 bn line of credit
Source: IRIS | 21 Jul, 2017, 03.51PM
Comments  |  Post Comment

Dwarikesh Sugar Industries (DSIL), a leading sugar producer in the country, has got upgraded credit rating from rating agency ICRA for its Rs 5.99 billion Line of Credit.
 
The Rating Committee of ICRA, after due consideration has upgraded the long-term rating to [ICRA]A+ (pronounced ICRA A plus) from [ICRA]A- for the Rs 5.99 billion Line of Credit of the company. The outlook on the long-term rating is stable.
 
According to ICRA rationale, ''the rating upgrade factors in the better-than-anticipated operational and financial performance of DSIL in FY2017 as well as the fact that the bulk of its operational cash flows have been used to reduce debt levels and thereby, improve debt metrics.''
 
''This apart, ICRA has factored in the continued favourable outlook for its core sugar business in FY2018, supported by the recent hike in import duty and a tight domestic stock situation. This is likely to support the sugar prices in the near term, and is expected to result in healthy profits and accruals in FY2018 as well.''
 
''Consequently, ICRA expects DSIL to use these cash flows for further debt repayment and largely complete its long-term debt obligations by March 31, 2018. The ratings continue to factor in the company's forward integration into cogeneration and distillery businesses, which provide alternate revenue streams and reduce the impact of the cyclicality of the sugar business to an extent.''

Shares of the company gained Rs 11.35, or 2.6%, to trade at Rs 448.50. The total volume of shares traded was 104,658 at the BSE (3.41 p.m., Friday).





Dwarikesh Sugar Industries Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Glenmark Pharma presents findings from Phase 2a study of GBR 830 - 19-Feb-2018 10:10
L&T Construction secures order worth Rs 16.80 bn - 19-Feb-2018 09:52
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer